Development of a Robust Mammalian Cell-based Assay for Studying Recombinant α4β1/3δ GABAAReceptor Subtypes-Reference-Cited by-同舟云学术

Development of a Robust Mammalian Cell-based Assay for Studying Recombinant α4β1/3δ GABAAReceptor Subtypes

Published:2017-05-25 Issue:2 Volume:121 Page:119-129
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Falk-Petersen Christina B.¹,Søgaard Rikke¹,Madsen Kenneth L.²,Klein Anders B.¹,Frølund Bente¹,Wellendorph Petrine¹

Affiliation:

1. Department of Drug Design and Pharmacology; Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark

2. Molecular Neuropharmacology and Genetics Laboratory; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Department of Neuroscience and Pharmacology; Faculty of Health and Medical Sciences; The Panum Institute; University of Copenhagen; Copenhagen Denmark

Funder

Lundbeckfonden

Sundhed og Sygdom, Det Frie Forskningsråd

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12778/fullpdf

Reference43 articles.

1. GABAA receptors: subtypes provide diversity of function and pharmacology;Olsen;Neuropharmacology,2009

2. Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors;Farrant;Nat Rev Neurosci,2005